Boston Scientific

OverviewSuggest Edit

Boston Scientific is a developer, manufacturer, and marketer of medical devices. It offers pacemakers, defibrillators, remote patient monitoring and diagnostic monitoring solutions, spinal cord stimulator systems, a range of catheters, Chronic Total Occlusion (CTO) systems, direct visualization systems, fiducial markers, forceps, guidewires, lasers, fibers, lifting agents, needles, penile prosthesis, retrieval devices, slings, snares, stents, ureteroscopes, vein ablation solutions, thrombectomy systems, sphincterotomes, and other products. The company caters to endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology and pelvic health segments.
TypePublic
Founded1979
HQMarlborough, MA, US
Websitebostonscientific.com
Employee Ratings4.2
Overall CultureA

Latest Updates

Employees (est.) (Dec 2021)41,000(+8%)
Job Openings1,128
Revenue (FY, 2021)$11.9 B(+20%)
Share Price (Aug 2022)$41
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Boston Scientific

Michael F Mahoney

Michael F Mahoney

Chairman and Chief Executive Officer
Daniel J. Brennan

Daniel J. Brennan

Executive Vice President and Chief Financial Officer
Edward MacKey

Edward MacKey

Executive Vice President, Global Operations
Art Butcher

Art Butcher

Executive Vice President and President, Asia Pacific
Wendy Carruthers

Wendy Carruthers

Senior Vice President, Human Resources
Jodi Eddy

Jodi Eddy

Senior Vice President and Chief Information and Digital Officer
Show more

Boston Scientific Office Locations

Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 25 other locations
Marlborough, MA, US (HQ)
300 Boston Scientific Way, Marlborough
Arden Hills, MN, US
4100 Hamline Ave N
Maple Grove, MN, US
1 Scimed Pl
San Jose, CA, US
150 Baytech Dr
Santa Clarita, CA, US
25155 Rye Canyon Loop, Valencia
Spencer, IN, US
780 Brookside Dr
Show all (29)

Boston Scientific Financials and Metrics

Boston Scientific Revenue

Embed Graph
View revenue for all periods
Boston Scientific's revenue was reported to be $11.89 b in FY, 2021
USD

Revenue (Q1, 2022)

3.0b

Gross profit (Q1, 2022)

2.1b

Gross profit margin (Q1, 2022), %

68.4%

Net income (Q1, 2022)

110.0m

EBIT (Q1, 2022)

466.0m

Market capitalization (1-Aug-2022)

58.5b

Closing stock price (1-Aug-2022)

41.0

Cash (31-Mar-2022)

325.0m

EV

67.5b
Boston Scientific's current market capitalization is $58.5 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

10.7b9.9b11.9b

Revenue growth, %

9%(8%)

Cost of goods sold

3.1b3.5b3.7b

Gross profit

7.6b6.4b8.2b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

2.5b2.0b2.7b2.8b3.1b2.9b3.0b

Cost of goods sold

806.0m791.0m869.0m894.0m945.0m900.0m955.0m

Gross profit

1.7b1.2b1.8b1.9b2.1b2.0b2.1b

Gross profit Margin, %

68%61%67%68%69%69%68%
Annual
USDFY, 2019FY, 2020FY, 2021

Cash

217.0m1.7b1.9b

Accounts Receivable

1.8b1.5b1.8b

Inventories

1.6b1.4b1.6b

Current Assets

4.7b6.7b6.3b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Cash

370.0m1.7b2.0b2.0b2.7b1.9b325.0m

Accounts Receivable

1.6b1.5b1.6b1.6b1.7b1.7b1.9b

Inventories

1.6b1.5b1.5b1.4b1.4b1.6b1.7b

Current Assets

4.8b5.8b6.2b6.1b6.8b6.2b5.1b
Annual
USDFY, 2019FY, 2020FY, 2021

Net Income

4.7b(82.0m)1.0b

Depreciation and Amortization

1.0b1.1b1.1b

Inventories

(290.0m)(65.0m)(346.0m)

Accounts Payable

111.0m88.0m408.0m
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Net Income

11.0m341.0m527.0m946.0m110.0m

Depreciation and Amortization

268.0m531.0m803.0m274.0m

Inventories

(115.0m)(100.0m)(315.0m)(108.0m)

Accounts Payable

(10.0m)187.0m275.0m(368.0m)
USDFY, 2019

EV/EBIT

47.8 x

EV/CFO

39.5 x

Revenue/Employee

298.2k

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

P/E Ratio

13.6
Show all financial metrics

Boston Scientific Operating Metrics

FY, 2018FY, 2019FY, 2020FY, 2021

Countries

130120120120

Medical Institutions Covered (U.S.)

35 k37 k35 k35 k

Patent Applications

5 k6 k6 k6 k

Patents Issued

19 k21 k18 k18 k

Boston Scientific Acquisitions / Subsidiaries

Company NameDateDeal Size
Baylis Medical CompanyOctober 06, 2021$1.75 b
Devoro Medical, Inc.September 21, 2021$320 m
Lumenis Surgical DivisionMarch 03, 2021$1.1 b
Preventice SolutionsJanuary 21, 2021$925 k
FarapulseSeptember 21, 2020
VertiFlexMay 09, 2019$465 m
BTGNovember 19, 2018$4.2 b
AugmenixSeptember 10, 2018$600 m
SpaceOARSeptember 07, 2018$600 m
VenitiAugust 08, 2018$160 m
Show more

Boston Scientific Revenue Breakdown

Embed Graph

Boston Scientific revenue breakdown by business segment: 31.3% from MedSurg, 40.9% from Cardiovascular, 27.7% from Rhythm Management and 0.1% from Other

Boston Scientific revenue breakdown by geographic segment: 17.4% from APAC, 21.2% from EMEA, 58.1% from U.S. and 3.3% from Other

Boston Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Boston Scientific Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Boston Scientific Online and Social Media Presence

Embed Graph

Boston Scientific Company Culture

  • Overall Culture

    A

    77/100

  • CEO Rating

    A+

    86/100

  • Compensation

    A-

    76/100

  • Diversity

    A-

    76/100

Learn more on Comparably

Boston Scientific News and Updates

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations

Parties Reach an Agreement that Concludes Outstanding Intellectual Property Disputes REDWOOD CITY, Calif., Aug. 1, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO) and Boston Scientific Corp. (NYSE: BSX) announced today that they have reached a settlement in their ongoing intellectual...

Global Smart Pills Market Report 2022-2027: Featuring Key Players Medtronic, Philips Healthcare, Boston Scientific Corporation & Others

Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Global Smart Pills Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48 billion in 2022 at a compound annual growth rate (CAGR) of 11.2%. …

Boston Scientific tops profit and sales expectations, but trims full-year outlook

Boston Scientific Corp. reported Wednesday second-quarter profit and sales that topped expectations, but trimmed its full-year outlook, saying it maintained "strong" market positions amid continued macroeconomic challenges. The medical devices company's stock was still inactive in premarket trading…

Boston Scientific Announces Results for Second Quarter 2022

MARLBOROUGH, Mass., July 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 percent on a reported basis, 9.6 percent on an operational1 basis and 6.6 percent on an organic2 basis, all...

Global Electrosurgical Devices Market (2022 to 2027) - Featuring Applied Medical Resources, B Braun Melsungen and Boston Scientific Among Others

DUBLIN, July 26, 2022 /PRNewswire/ -- The "Global Electrosurgical Devices Market (2022-2027) by Type, Application, End User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global...

Patient Monitoring Devices Global Market Report 2022: Featuring Key Players Abbott Laboratories, Boston Scientific, Honeywell International & Others

Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Patient Monitoring Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering.
Show more

Boston Scientific Frequently Asked Questions

  • When was Boston Scientific founded?

    Boston Scientific was founded in 1979.

  • Who are Boston Scientific key executives?

    Boston Scientific's key executives are Michael F Mahoney, Daniel J. Brennan and Edward MacKey.

  • How many employees does Boston Scientific have?

    Boston Scientific has 41,000 employees.

  • What is Boston Scientific revenue?

    Latest Boston Scientific annual revenue is $11.9 b.

  • What is Boston Scientific revenue per employee?

    Latest Boston Scientific revenue per employee is $290 k.

  • Who are Boston Scientific competitors?

    Competitors of Boston Scientific include Baxter International, Johnson & Johnson and Abbott.

  • Where is Boston Scientific headquarters?

    Boston Scientific headquarters is located at 300 Boston Scientific Way, Marlborough, Marlborough.

  • Where are Boston Scientific offices?

    Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 25 other locations.

  • How many offices does Boston Scientific have?

    Boston Scientific has 29 offices.